147 related articles for article (PubMed ID: 1974508)
1. Efficacy and safety of carvedilol in renal hypertension. A multicenter open trial.
Takeda T; Kohno M; Ishii M; Kubo S; Saruta T; Mizuno Y; Fukiyama K; Fujishima M; Yoshimura M
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S158-63. PubMed ID: 1974508
[TBL] [Abstract][Full Text] [Related]
2. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic benefits and safety of carvedilol in the treatment of renal hypertension. An open, short term study. Carvedilol Renal Hypertension Study Group in Japan.
Kohno M; Takeda T; Ishii M; Saruta T; Mizuno Y; Yoshimura M; Kubo S; Fukiyama K; Fujishima M
Drugs; 1988; 36 Suppl 6():129-35. PubMed ID: 2908299
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
Ollivier JP; Durier P; Bussiere JL; Gayet JL
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
[TBL] [Abstract][Full Text] [Related]
5. The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics.
Dupont AG; Schoors DF; Venuti RP
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S153-7. PubMed ID: 1974507
[TBL] [Abstract][Full Text] [Related]
6. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
Widmann L; van der Does R; Hörrmann M; Machwirth M
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S143-6. PubMed ID: 1974505
[TBL] [Abstract][Full Text] [Related]
7. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
Ogihara T; Ikeda M; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S108-12. PubMed ID: 2454355
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term carvedilol therapy on renal function in essential hypertension.
Tomita K; Marumo F
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S97-101. PubMed ID: 1378158
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
van der Does R; Widmann L; Uberbacher HJ; Hörrmann M; Machwirth M; Stienen U
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S147-52. PubMed ID: 1974506
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
Ruilope LM
Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of carvedilol in severe hypertension.
Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
[TBL] [Abstract][Full Text] [Related]
14. Dose-effect relationship of carvedilol in essential hypertension. An open study.
Ogihara T; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T; Arakawa K
Drugs; 1988; 36 Suppl 6():75-81. PubMed ID: 2908305
[TBL] [Abstract][Full Text] [Related]
15. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.
Forrest EH; Bouchier IA; Hayes PC
J Hepatol; 1996 Dec; 25(6):909-15. PubMed ID: 9007720
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
[TBL] [Abstract][Full Text] [Related]
17. The use of carvedilol in elderly hypertensive patients.
Morgan TO; Anderson A; Cripps J; Adam W
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S129-33. PubMed ID: 1974503
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
Albergati F; Paternó E; Venuti RP; Boeri D; Lombardo I; Semino S; Viviani GL; Adezati L
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S86-9. PubMed ID: 1378156
[TBL] [Abstract][Full Text] [Related]
19. Effects of carvedilol on serum lipids in hypertensive and normotensive subjects.
Seguchi H; Nakamura H; Aosaki N; Homma Y; Mikami Y; Takahashi S
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S139-42. PubMed ID: 1974504
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study.
Kim EJ; Song WH; Lee JU; Shin MS; Lee S; Kim BO; Hong KS; Han SW; Park CG; Seo HS
Hypertens Res; 2014 Jan; 37(1):50-6. PubMed ID: 24026037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
